AI in Biopharma Innovation and Regulatory Challenges - with Nishtha Jain of Takeda Pharmaceuticals

AI in Biopharma Innovation and Regulatory Challenges - with Nishtha Jain of Takeda Pharmaceuticals

0 Recensioner
0
Episod
923 of 1034
Längd
26min
Språk
Engelska
Format
Kategori
Ekonomi & Business

Today’s guest is Nishtha Jain, Head of Innovation and Digital Technology at Takeda Pharmaceuticals. Nistha returns to the program to discuss the transformative impact of AI across the pharmaceutical value chain. She and Emerj Editorial Director Matthew DeMello explore how AI is improving drug development efficiency, addressing data challenges, and overcoming regulatory hurdles. She highlights key breakthroughs like Google DeepMind’s AlphaFold and AI-assisted clinical trial optimization, emphasizing the potential for faster, more cost-effective drug development. The discussion also covers the challenges of AI adoption, including data accessibility, regulatory compliance, and ethical considerations like bias in AI models. If you’ve enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show!


Lyssna när som helst, var som helst

Kliv in i en oändlig värld av stories

  • 1 miljon stories
  • Hundratals nya stories varje vecka
  • Få tillgång till exklusivt innehåll
  • Avsluta när du vill
Starta erbjudandet
SE - Details page - Device banner - 894x1036
Cover for AI in Biopharma Innovation and Regulatory Challenges - with Nishtha Jain of Takeda Pharmaceuticals

Andra podcasts som du kanske gillar...